SCHEMBL5805401

SCHEMBL5805401

O=C(CN1CCCCC1c1ccc2c(c1)OCCO2)Nc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
LMNA P02545 7/20 0.47
MAPT P10636 7/20 0.47
TP53 P04637 2/20 0.47
ALDH1A1 P00352 7/20 0.47
HTT P42858 3/20 0.47
MAPK1 P28482 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
NPSR1 Q6W5P4 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2D6 P10635 3/20 0.46
CYP2C19 P33261 3/20 0.46
CYP2C9 P11712 2/20 0.46
GAA P10253 2/20 0.46
USP2 O75604 2/20 0.46
CYP1A2 P05177 1/20 0.46
TSHR P16473 1/20 0.45
ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5808924 0.95 LMNA (0.47) NCOA1NCOA3LMNAMAPTTP53
SCHEMBL5796637 0.82 LMNA (0.59) LMNAMAPTTP53ALDH1A1HTT
SCHEMBL5811144 0.79 ULK1 (0.37) NCOA1NCOA3MAPTALDH1A1SMN1; SMN2
SCHEMBL5820332 0.75 LMNA (0.54) LMNAMAPTALDH1A1HTTMAPK1
SCHEMBL5794482 0.75 MAPT (0.56) LMNAMAPTTP53ALDH1A1HTT
SCHEMBL21498009 0.73 MAPT (0.72) LMNAMAPTTP53ALDH1A1HTT
SCHEMBL5795178 0.70 SMN1; SMN2 (0.54) LMNAMAPTALDH1A1HTTL3MBTL1
SCHEMBL19668244 0.68 KDR (0.72) LMNAMAPTHTTMAPK1SMN1; SMN2
SCHEMBL26546756 0.68 KDR (0.76) LMNAMAPTTP53ALDH1A1HTT
SCHEMBL7292316 0.67 MAPT (0.69) LMNAMAPTTP53ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006015279-A1 HETEROCYCLIC DIAMINE COMPOUNDS AS LIGANDS OF THE MELANIN CONCENTRATING HORMONE RECEPTOR USEFUL FOR THE TREATMENT OF OBESITY, DIABETES, EATING AND SEXUAL DISORDERS NEUROGEN CORPORATION (US) 2006-02-09 WO claimed